2025 HCPCS Code C9760
Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
TAGS: investigational device interatrial guidance right exemption imaging performed transcatheter transeptal approved class echocardiography procedure heart implantation studyShort Description | Non-blind interatrial shunt |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Code Added Date | July 01, 2020 |
HCPCS Action Effective Date | January 01, 2021 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Type Of Service Code | 2 - Surgery |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9461 - Choline c 11, diagnostic
- C9462 - Injection, delafloxacin
- C9463 - Injection, aprepitant
- C9464 - Injection, rolapitant
- C9465 - Injection, durolane
- C9466 - Injection, benralizumab
- C9467 - Inj rituximab hyaluronidase
- C9468 - Inj, factor ix, rebinyn
- C9469 - Inj triamcinolone acetonide
- C9470 - Aripiprazole lauroxil im
- C9471 - Hymovis, 1 mg
- C9472 - Inj talimogene laherparepvec
- C9473 - Injection, mepolizumab
- C9474 - Inj, irinotecan liposome
- C9475 - Injection, necitumumab
- C9476 - Injection, daratumumab
- C9477 - Injection, elotuzumab
- C9478 - Injection, sebelipase alfa
- C9479 - Instill, ciprofloxacin otic
- C9480 - Injection, trabectedin